Galveston, TX, United States of America

Diego Rincon-Limas

This inventor holds 1 USPTO granted patent. Top assignee: Baylor College of Medicine. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Diego Rincon-Limas. Retrieved from https://idiyas.com/inventor/diego-rincon-limas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Diego Rincon-Limas: Innovator in Neurodegenerative Disorder Research

Introduction

Diego Rincon-Limas is a prominent inventor based in Galveston, TX (US). He has made significant contributions to the field of neurodegenerative disorders through his innovative research and patent.

Latest Patents

Diego holds a patent for a model designed for neurodegenerative disorders. The invention discloses a double transgenic fly that expresses both Tau protein and the human Aβ42 peptide of human amyloid-β precursor protein (APP). This model exhibits a synergistic altered phenotype compared to transgenic flies expressing either Tau or human Aβ42 alone. It provides an improved model for studying neurodegenerative disorders, such as Alzheimer's disease. Additionally, the invention outlines methods for identifying therapeutic compounds to treat these disorders using the double transgenic flies.

Career Highlights

Diego Rincon-Limas is affiliated with Baylor College of Medicine, where he conducts his research. His work has garnered attention for its potential impact on understanding and treating neurodegenerative diseases.

Collaborations

Diego collaborates with notable colleagues, including Juan Botas and Pedro Fernandez-Funez. Their combined expertise enhances the research efforts in the field of neurodegenerative disorders.

Conclusion

Diego Rincon-Limas is a key figure in the research of neurodegenerative disorders, with a focus on innovative models that could lead to significant advancements in treatment options. His contributions are vital to the ongoing fight against diseases like Alzheimer's.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…